Diversity and Inclusion
Who Gets Access to Innovative Treatments?
In this episode of the Health & Veritas podcast, Harlan Krumholz reports on a new study testing the effectiveness of the OCD drug fluvoxamine in treating COVID, and Howard Forman reflects on the potential of continuous glucose monitoring for people with diabetes. And they’re joined by Dr. Utibe Essien of the University of Pittsburgh to discuss the barriers preventing people of color from getting innovative new treatments and medications.
Integrated Communities Benefit More from Venture Capital
A new study suggests that mixing people of diverse backgrounds leads to more innovation and more economic growth.
Can the Police Regain Trust?
The United States is engaged in a fraught debate over the role of police in the community. Yale Law School professor Tracey Meares describes what’s at stake and proposes approaches to reform.
What do leaders need to understand about diversity?
In globalized, multicultural organizations, leaders need to learn to create value out of diversity.
Can we fix discrimination in markets?
Studies and anecdotal evidence suggest that 40 years after the civil rights era, African Americans still find themselves under scrutiny in retail stores and women pay higher prices at car dealerships. How can we ensure fair treatment in markets?
